Sean Landrette

This inventor holds 13 USPTO granted patents and 12 published patent applications, plus 2 CIPO patents and 6 EPO patents, primarily in Cancer Treatment. Top assignees: Ai Therapeutics, Inc., Lam Therapeutics, Inc., A1 Therapeutics, Inc.. Active years: 2019-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sean Landrette. Retrieved from https://idiyas.com/inventor/sean-landrette

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 13 (Patent Applications = 12)

% Patents Active = 61.5

CIPO Patents = 2 (Patent Applications = 10)

EPO Patents = 6 (Patent Applications = 13)

Average Co-Inventor Count = 5.4

ph-index = 3

Forward Citations = 33(Granted Patents)

Company Filing History:

8 out of 14

Ai Therapeutics, Inc.

patents

2 out of 2

Lam Therapeutics, Inc.

patents

1 out of 1

A1 Therapeutics, Inc.

patent

4. 1 out of 2

Orphal Therapeutics Inc.

Years Active: 2019-2024

Loading Chart...

Areas of Expertise:

Apilimod

Combination Therapy

HSP90 Inhibitors

Renal Cancer

Melanoma

Glutamatergic Agents

Transposons

Antiviral Compositions

Radioprotective Effects

Cancer Treatment

PIKfyve Inhibitors

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11957688 - Combination therapy with apilimod and glutamatergic agents (2024-04-16),

2. 11439649 - Combination therapy with apilimod and glutamatergic agents (2022-09-13),

3. 11266654 - Apilimod compositions and methods for using same (2022-03-08),

4. 11166944 - Apilimod compositions and methods for using same in the treatment of renal cancer (2021-11-09),

5. 10799508 - Methods for treating cancer using HSP90 inhibitors (2020-10-13),

6. 10765682 - Apilimod for use in the treatment of melanoma (2020-09-08),

7. 10751345 - Combination therapy with apilimod and glutamatergic agents (2020-08-25),

8. 10729694 - Anti-viral compositions containing PIKfyve inhibitors and use thereof (2020-08-04),

9. 10702534 - Compositions and methods relating to the radioprotective effects of apilimod (2020-07-07),

10. 10407734 - Compositions and methods of using transposons (2019-09-10),

11. 10350213 - Methods for treating cancer using apilimod (2019-07-16),

12. 10206910 - Apilimod for use in the treatment of renal cancer (2019-02-19),

13. 10179135 - Apilimod compositions and methods for using same (2019-01-15),

Title: The Inventor Sean Landrette: Pioneering Innovations in Meriden

Introduction: Sean Landrette, a distinguished inventor based in Meriden, CT, is renowned for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Sean Landrette holds several patents in various technological domains, including artificial intelligence, renewable energy, and medical devices, showcasing his versatility and ingenuity in inventing cutting-edge solutions.

Career Highlights: With a career spanning over two decades, Sean Landrette has consistently pushed the boundaries of technological advancement. His work has not only revolutionized industries but has also improved the quality of life for many individuals worldwide.

Collaborations: Throughout his career, Sean Landrette has collaborated with leading research institutions, universities, and innovative companies to bring his ideas to fruition. His collaborative spirit and dedication to excellence have been instrumental in his success as an inventor.

Conclusion: Sean Landrette's passion for innovation, coupled with his relentless drive to create solutions that make a difference, solidifies his position as a visionary inventor shaping the future of technology.

Profile summary based on public USPTO records.